Bausch Health Companies Inc. (BHC): Price and Financial Metrics

BHC POWR Grades

• BHC scores best on the Growth dimension, with a Growth rank ahead of 98.73% of US stocks.
• BHC's strongest trending metric is Stability; it's been moving up over the last 177 days.
• BHC ranks lowest in Momentum; there it ranks in the 7th percentile.

BHC Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for BHC is -11.74 -- better than only 1.63% of US stocks.
• BHC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 0.35% of US stocks.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for BHC comes in at 42.48% -- higher than that of 95.44% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to BAUSCH HEALTH COMPANIES INC, a group of peers worth examining would be LVO, RGS, CCLP, AZYO, and LCI.
• Visit BHC's SEC page to see the company's official filings. To visit the company's web site, go to www.bauschhealth.com.

BHC Valuation Summary

• In comparison to the median Healthcare stock, BHC's price/sales ratio is 84.21% lower, now standing at 0.3.
• Over the past 243 months, BHC's price/sales ratio has gone down 10.8.

Below are key valuation metrics over time for BHC.

BHC Growth Metrics

Its year over year net cashflow from operations growth rate is now at -28.85%.
• Its year over year price growth rate is now at -66.36%.
• The 3 year revenue growth rate now stands at -0.9%.

BHC's revenue has moved down $474,000,000 over the prior 33 months.

The table below shows BHC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	8,127	-1,179	254
2022-06-30	8,192	648	43
2022-03-31	8,325	920	-407
2021-12-31	8,434	1,426	-948
2021-09-30	8,451	1,796	-1,170
2021-06-30	8,478	1,488	-1,287

BHC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BHC has a Quality Grade of C, ranking ahead of 53.93% of graded US stocks.
• BHC's asset turnover comes in at 0.276 -- ranking 162nd of 680 Pharmaceutical Products stocks.
• CCXI, NBY, and LLY are the stocks whose asset turnover ratios are most correlated with BHC.

The table below shows BHC's key quality metrics over time.